US Medicare "pass-through" change good news for industry
This article was originally published in Clinica
The US device industry is applauding a possible change in what it takes for a product to be considered for the pass-through payment in the Medicare programme. Devices have traditionally had to be surgically implanted or inserted through an open surgical incision to meet the pass-through criteria.
You may also be interested in...
New rules in India specify that a marketer of a drug will share the onus for quality and compliance along with the manufacturer. Enhanced punishment for misleading advertisements for a range of illnesses is also proposed, while calls for a statute to regulate pharma's marketing practices grow louder.
Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm Advent International.